Getting from R&D to IND – Pitfalls to avoid and how to succeed

The road to IND isn’t always easy. Balancing speed, risk, and future needs is a challenge. Join Paul Jorjorian, Vice President and General Manager, Thermo Fisher Scientific, to learn how you can take your molecule from discovery through to FiH trials, balancing risk and accelerated timelines while ensuring a stable foundation for future scale-up and commercialization.

We’ll discuss:

Related Sites

Additional Resources